Abiomed and Oscor Warn of Catheter Introducer Leakage Risk
Abiomed and Oscor reported a potential leakage issue in their introducer sheaths that may lead to increased access-site bleeding.
Asset / Drug
Drug and asset intelligence for Abiomed with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.